AdipoRon hydrochloride is a orally active AdipoR1 and AdipoR2 agonist; antidiabetic.
AdipoRon hydrochloride is a orally active AdipoR1 and AdipoR2 agonist; antidiabetic.
AdipoRon hydrochloride is a orally active AdipoR1 and AdipoR2 agonist; antidiabetic.
Adjudin (also known as AF-2364) is a potent Cl- channel blocker, with a superior mitochondria-inhibitory effect. Adjudin (AF-2364) attenuates microglia activation by suppression of the NF-κB pathway.
Adjudin (also known as AF-2364) is a potent Cl- channel blocker, with a superior mitochondria-inhibitory effect. Adjudin (AF-2364) attenuates microglia activation by suppression of the NF-κB pathway.
Adjudin (also known as AF-2364) is a potent Cl- channel blocker, with a superior mitochondria-inhibitory effect. Adjudin (AF-2364) attenuates microglia activation by suppression of the NF-κB pathway.
ADL5859 is a potent, selective and orally bioavailable δ-opioid receptor agonist (Ki = 0.84 nM, EC50 = 20 nM).
ADL5859 is a potent, selective and orally bioavailable δ-opioid receptor agonist (Ki = 0.84 nM, EC50 = 20 nM).
ADL5859 is a potent, selective and orally bioavailable δ-opioid receptor agonist (Ki = 0.84 nM, EC50 = 20 nM).
Adomeglivant (LY2409021) is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus.
Adomeglivant (LY2409021) is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus.